Coya Therapeutics (COYA) Depreciation & Amortization - Total (2022 - 2026)

Coya Therapeutics has disclosed Depreciation & Amortization - Total across 5 years of filings, most recently posting $2807.0 for Q2 2026.

• In Q2 2026, Depreciation & Amortization - Total fell 58.96% year-over-year to $2807.0; the TTM figure through Jun 2026 stood at $19295.0 (down 29.48% YoY), while the FY2025 annual figure was $27361.0, changed 0.0% from the prior year.
• Depreciation & Amortization - Total came in at $2807.0 for Q2 2026 at Coya Therapeutics, roughly flat from $2807.0 in the prior quarter.
• In the past five years, Depreciation & Amortization - Total ranged from a high of $12455.0 in Q3 2022 to a low of $2807.0 in Q1 2026.
• Average Depreciation & Amortization - Total over 5 years is $6392.1, with a median of $6840.0 recorded in 2022.
• Year-over-year, Depreciation & Amortization - Total surged 69.6% in 2023 and plunged 58.96% in 2026.
• Over 5 years, Depreciation & Amortization - Total stood at $6840.0 in 2022, then changed by 0.0% to $6840.0 in 2023, then changed by 0.0% to $6840.0 in 2024, then increased by 0.01% to $6841.0 in 2025, then sank by 58.97% to $2807.0 in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization - Total figures were $2807.0 in Q2 2026, $2807.0 in Q1 2026, and $6841.0 in Q4 2025.